News

Isansys Lifecare Hires New UK Sales Manager


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Isansys Lifecare Hires New UK Sales Manager

 Tuesday, March 07, 2017 -  - Personnel Changes 

Abingdon, UK: Isansys Lifecare, the market leader in new generation wireless patient monitoring technology and patient digitisation systems and services, today announced the hiring of Sam Thwaites as its new UK Sales Manager, reporting to CEO Keith Errey.

Sam’s diverse go-to-market experience is based on building high-growth, scalable sales teams and channel structures while driving sales and gaining market share. His understanding of the medical device industry will enable him to work closely with healthcare communities and clinicians to facilitate their learning and understanding of Isansys Lifecare and its Patient Status Engine, an innovative patient monitoring platform which enables the early detection of deterioration in patients.

He will aid healthcare professionals who want to improve the health outcomes of their patients and reduce overall costs of care for their organisations by adopting the Isansys technology. He will also spend time securing more partnerships with hospitals within the UK, in addition to those with which Isansys is currently working including Birmingham Children’s Hospital, Birmingham, The Royal Free, London, The Queen Elizabeth Hospital, Birmingham, The Wishaw Hospital, Glasgow, and The Royal Hospital for Children, Glasgow.

Keith Errey, CEO of Isansys, said: “This is an important step for us and shows our commitment to the NHS and patients in the UK who should also be the beneficiaries of this unique UK developed technology which is proving so beneficial for patients and healthcare providers in other parts of the world.”

Isansys Lifecare is a best in class digital healthcare company which has created and developed the Patient Status Engine. With adequate warning of adverse events, clinicians can use the technology to intervene more quickly and confidently and enable patient outcomes to be improved.

Clinical teams globally are already using the data collected by the PSE to gain insights into the future health status of their patients, which is achieved through data-driven methods such as predictive algorithms and the automatic calculation of Early Warning Scores.

Isansys is currently setting up another entity into the European market and is in the process of submitting a 510(k) application to the FDA later this year in order to gain approval to commercialise the PSE technology in the US. More news about this will follow shortly.

-Ends-

For further information, please contact:

Isansys Lifecare
Georgina Horton, PR and Marketing Executive
Tel: 01235 436229
Mob: 07852 181898
Email: georgina.horton@isansys.com


Notes to Editors

About Isansys

Isansys is a best in class digital healthcare company developing an innovative patient monitoring platform, enabling the early detection of deterioration in patients. With adequate warning of adverse events, clinicians can intervene more quickly and confidently and patient outcomes can be improved. The Patient Status Engine (PSE), Isansys’ proprietary technology platform, is a complete end-to-end, CE marked, Class IIa medical device which uses wireless body-worn sensors to automatically collect and analyse vital signs continuously and in real-time using proprietary algorithms. This data is then streamed via a proprietary patient gateway network and delivered to the nurses’ station or remotely to clinicians.

Clinical teams globally are already using the data collected and analysed by the PSE to gain insights into the future health status of their patients, which is achieved through data-driven methods such as predictive algorithms, the automatic   calculation of Early Warning Scores, and new physiologically based biomarkers. These enable clinicians and nurses to improve patient outcomes and reduce the costs of dealing with patient safety issues in order to shorten hospital stays and facilitate proactive care. The wireless nature of the PSE also means patients can be monitored in hospitals, in the community or at home.

Isansys proprietary technology platform, Patient Status Engine (PSE), was first launched in 2013, with a second generation technology introduced in November 2015.

Isansys is a privately held company based in Abingdon. For more information, please visit www.isansys.com


© Catalyst Innovation Portal 2019